CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA

Tom Reuvekamp; Lok Lam Ngai; Daphne den Hartog; Jannemieke Carbaat-Ham; Mona M H E Fayed; Willemijn J Scholten; Tim R Mocking; Dana A Chitu; Thomas Pabst; Saskia K Klein; Georg Stussi; Laimonas Griskevicius; Dimitri Breems; Danielle van Lammeren-Venema; Rinske Boersma; Gert J Ossenkoppele; Arjan A van de Loosdrecht; Costa Bachas; Gerwin A. Huls; David C de Leeuw; Jacqueline Cloos; D.C. de Leeuw

doi:10.1038/s41375-025-02539-0

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA

Tom Reuvekamp
, Lok Lam Ngai
, Daphne den Hartog
, Jannemieke Carbaat-Ham
, Mona M H E Fayed
, Willemijn J Scholten
, Tim R Mocking
, Dana A Chitu
, Thomas Pabst
, Saskia K Klein
, Georg Stussi
, Laimonas Griskevicius
, Dimitri Breems
, Danielle van Lammeren-Venema
, Rinske Boersma
, Gert J Ossenkoppele
, Arjan A van de Loosdrecht
, Costa Bachas
, Gerwin A. Huls
, David C de Leeuw

Jacqueline Cloos, D.C. de Leeuw

Department of Hematology
Hemato Oncology Foundation for Adults in the Netherlands
University Hospital
University Medical Center Groningen
Vilnius University Hospital Santaros Klinikos
Amphia Hospital

Research output: Contribution to journal › Article › Academic › peer-review

31 Downloads (Pure)

Original language	English
Pages (from-to)	972-975
Number of pages	4
Journal	Leukemia
Volume	39
Issue number	4
Early online date	27 Feb 2025
DOIs	https://doi.org/10.1038/s41375-025-02539-0
Publication status	Published - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41375-025-02539-0

Cd34cd38--leukemia-stem-cells-predict-clinical-outcomes-in-acute-myeloid-leukemia-patients-treated-non-intensively-with.pdfFinal published version, 942 KBLicence: CC BY

Cite this

Reuvekamp, T., Ngai, L. L., den Hartog, D., Carbaat-Ham, J., Fayed, M. M. H. E., Scholten, W. J., Mocking, T. R., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Breems, D., van Lammeren-Venema, D., Boersma, R., Ossenkoppele, G. J., van de Loosdrecht, A. A., Bachas, C., Huls, G. A., ... de Leeuw, D. C. (2025). CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA. Leukemia, 39(4), 972-975. https://doi.org/10.1038/s41375-025-02539-0

@article{06bdd99f5f694b598143ee6d8f061590,

title = "CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA",

author = "Tom Reuvekamp and Ngai, \{Lok Lam\} and \{den Hartog\}, Daphne and Jannemieke Carbaat-Ham and Fayed, \{Mona M H E\} and Scholten, \{Willemijn J\} and Mocking, \{Tim R\} and Chitu, \{Dana A\} and Thomas Pabst and Klein, \{Saskia K\} and Georg Stussi and Laimonas Griskevicius and Dimitri Breems and \{van Lammeren-Venema\}, Danielle and Rinske Boersma and Ossenkoppele, \{Gert J\} and \{van de Loosdrecht\}, \{Arjan A\} and Costa Bachas and Huls, \{Gerwin A.\} and \{de Leeuw\}, \{David C\} and Jacqueline Cloos and \{de Leeuw\}, D.C.",

year = "2025",

month = apr,

doi = "10.1038/s41375-025-02539-0",

language = "English",

volume = "39",

pages = "972--975",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Reuvekamp, T , Ngai, LL, den Hartog, D, Carbaat-Ham, J, Fayed, MMHE, Scholten, WJ, Mocking, TR, Chitu, DA, Pabst, T, Klein, SK, Stussi, G, Griskevicius, L, Breems, D, van Lammeren-Venema, D, Boersma, R, Ossenkoppele, GJ, van de Loosdrecht, AA , Bachas, C, Huls, GA, de Leeuw, DC, Cloos, J & de Leeuw, DC 2025, 'CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA', Leukemia, vol. 39, no. 4, pp. 972-975. https://doi.org/10.1038/s41375-025-02539-0

TY - JOUR

T1 - CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

T2 - ACUTE MYELOID LEUKEMIA

AU - Reuvekamp, Tom

AU - Ngai, Lok Lam

AU - den Hartog, Daphne

AU - Carbaat-Ham, Jannemieke

AU - Fayed, Mona M H E

AU - Scholten, Willemijn J

AU - Mocking, Tim R

AU - Chitu, Dana A

AU - Pabst, Thomas

AU - Klein, Saskia K

AU - Stussi, Georg

AU - Griskevicius, Laimonas

AU - Breems, Dimitri

AU - van Lammeren-Venema, Danielle

AU - Boersma, Rinske

AU - Ossenkoppele, Gert J

AU - van de Loosdrecht, Arjan A

AU - Bachas, Costa

AU - Huls, Gerwin A.

AU - de Leeuw, David C

AU - Cloos, Jacqueline

AU - de Leeuw, D.C.

PY - 2025/4

Y1 - 2025/4

UR - https://www.scopus.com/pages/publications/86000113671

U2 - 10.1038/s41375-025-02539-0

DO - 10.1038/s41375-025-02539-0

M3 - Article

C2 - 40016301

SN - 0887-6924

VL - 39

SP - 972

EP - 975

JO - Leukemia

JF - Leukemia

IS - 4

ER -

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents: ACUTE MYELOID LEUKEMIA

UN SDGs

Access to Document

Other files and links

Cite this